CRP, which is produced by hepatocytes in response to IL-6 stimulation, is a cost-effective and widely available marker of inflammation that may also contribute to an immunosuppressive tumour microenvironment by directly impairing T-cell function [19, 20]. This evidence concerns the gene CRP and neoplasm.